Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrawound Vancomycin Powder in Spinal Fusion Surgery
NCT02631408Phase 4Completed
- Sponsor
- Orthopedic Hospital Speising
- Start
- Aug 2015
- Primary completion
- Mar 2019
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by Orthopedic Hospital Speising. Primary endpoint: Surgical Site Infection rate at 1 year. Started Aug 2015; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02631408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631408.